acute myeloid leukemia
2 stories
-
healthVenetoclax Combo Shows Strong Survival Gains in Older AML Patients
Phase II trial finds cladribine, low-dose cytarabine, and venetoclax alternating with azacitidine and venetoclax improves remission and survival in older AML patients.
-
healthTP53 Multihit Impact Mitigated in Del(5q) Myelodysplastic Neoplasms
Study finds TP53 multihit alterations in isolated del(5q) MDS show better survival and slower progression than other subtypes.